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It is fair to say that the NHS faces many challenges at present, none more so than the pressure 
to achieve improved quality and 
productivity under severe economic 
pressure. NHS organisations are 
increasingly having to call on external 
expertise to enable them to meet these 
challenges and there is a recognition that 
joint working can be beneficial. 
One example is the new 
partnership between the NHS and the 
pharmaceutical industry (Department 
of Health [DH], 2010a), where the 
DH and the Association of the British 
Pharmaceutical Industry (ABPI) have 
agreed to work together in the interest 
of improved patient outcomes.
Wound care clinicians and the 
commercial sector have developed 
pathways for assessing new products 
and developing education and 
companies do support clinicians by 
providing funding for research or 
product evaluations. However, it is fair 
to say that the relationship between the 
pharmaceutical industry and the NHS is 
rather more rigorous.
It is vital that the working relationships 
between wound care industry and 
clinicians are developed. Furthermore 
it is crucial that these partnerships are 
transparent (Glover, 2009).
of conferences, Smith and Nephew 
have clear boundaries concerning these 
business courtesies, which ensure that 
the educational event itself, and the 
associated networking, is the focus for 
the attendees (Shorney, 2006).
Eucomed
Eucomed (the European Medical 
Technology Industry Association) 
represents 4,500 designers, 
manufacturers and suppliers of medical 
technology. Members are required to 
adhere to Eucomed’s Code of Business 
Practice, which stresses the importance 
of the contribution of clinicians to the 
advancement of medical technology, 
safe and effective use of equipment 
and research and education. The Code 
provides a set of key principles:
8	Separation: interactions between 
industry and clinicians should not 
influence purchasing decisions. For 
example, a company should not 
expect a clinician to use its products 
simply because it sponsored the 
clinician’s place at a conference
8	Transparency: all interactions have to 
comply with local or national laws 
and professional codes of conduct, 
and the purpose of the interaction 
should be clearly stated 
8	Equivalence: if a clinician is paid by a 
company to perform a service, such 
as undertaking a product evaluation 
or presenting at a conference, any 
fee should be commensurate with 
the clinician’s normal remuneration. 
In other words, a nurse, should not 
be expected to receive more than 
the normal ‘hourly rate’
8	Documentation: a written agreement 
outlining the purpose, content, 
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The frameworks within which 
clinicians and the commercial world 
work should ensure that all legal, moral 
and accountability issues are addressed. 
For example, Smith and Nephew is 
committed to industry codes of conduct 
and ensuring that it works with its 
clinical partners in order to ensure 
that the best possible management 
approaches for patients are utilised 
(Glover, 2009). In addition to internal 
codes of conduct, companies like Smith 
and Nephew should operate within the 
following frameworks to ensure that 
rules governing basic business courtesies, 
training, education and company-
sponsored attendance at conferences 
are adhered to.
Surgical Dressing Manufacturers Association
The Surgical Dressing Manufacturers 
Association’s (SDMA) code of conduct 
clarifies how industry and customers 
should interact. For example, principles 
3.2 and 3.8 of the Code relate to 
business courtesies such as providing 
meals, social events, travel and living 
expenses at conferences/exhibitions. The 
Code states that expenses should not 
‘exceed a level normally associated with 
the customer’s lifestyle’. Essentially, this 
rule is there to prevent the ‘jollies’ often 
associated with healthcare companies in 
the past, such as ‘educational events’ that 
were little more than an exotic holiday 
with an hour or two of lectures. 
Thus, clinicians should no longer 
expect to be ‘wined and dined’ at the 
sponsoring company’s expense, and 
any hospitality should be secondary 
to education and training (Shorney, 
2006). When underwriting the costs 
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services and remuneration is 
required for any interactions. This 
ensures that both parties are happy 
with what is expected/required 
and how such an interaction will 
be conducted. This is particularly 
important in relation to, for example, 
ownership of information obtained 
from research and how this may  
be disseminated.
In essence, the Eucomed code 
reflects the principles outlined by the 
SDMA and further supports those that 
exist in the NMC Code (NMC, 2008).
The NMC Code
The NMC has developed and produced 
a plethora of documents that help guide 
practice and professional conduct. The 
Code (NMC, 2008) specifically outlines 
expected behaviours in relation to 
advertising and sponsorship. They  
state that:
8	Clinicians must be open and honest, 
act with integrity and uphold the 
reputation of the profession
8	Clinicians must ensure that any 
advice they give regarding healthcare 
products or services is evidence-
based
8	Clinicians must ensure that their 
professional judgment is not 
influenced by any commercial 
considerations.
Essentially, the Code is not saying 
that clinicians cannot work with 
companies for financial gain, rather 
that if they do it must be open and 
transparent. This is reflected in Smith 
and Nephew’s approach to working 
with clinicians.
Sponsorship by companies for 
attending conferences or supporting 
continued learning at universities is 
not frowned upon, however, it is the 
responsibility of clinicians to ensure 
that product choice is influenced by 
professional judgement, rather than any 
sponsorship (Glover, 2009).
Clinical governance
In addition to these company and 
professional codes of practice, quality 
indicators and clinical governance, if 
applied appropriately, can be used by 
all parties to ensure ethical ways of 
working. Indeed the ideals of tripartite 
working — where clinicians work 
together with industry and higher 
education institutes — should be 
embraced as a stable structure for 
partnership working (DH, 2010a).
Wound care quality indicators
The DH (2009) promised that there 
would be ‘safer care for patients, who 
can be confident that they will be 
protected from avoidable harm’ and 
the DH and the coalition government 
and industry can ultimately lead to 
improved patient outcomes. Under the 
guidance of the DH’s quality agenda, 
it is time for clinicians and industry 
to embrace partnership working 
and support the principles of patient 
safety, patient experience and clinical 
effectiveness. Building on the frameworks 
that already exist will allow ethical 
practice to thrive, which is imperative for 
industry and clinicians alike. 
The authors acknowledge the support of 
Real Healthcare Solutions and Smith and 
Nephew in producing this article.
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If a clinician is paid by a 
company to perform a 
service... any fee should be 
commensurate with her 
normal remuneration. 
are determined that this will become 
a reality. To this end, the DH (2010b) 
published a national programme of 
work streams focusing on long-term 
conditions, urgent care and end of life 
care that concentrate on improving 
quality and productivity across care 
pathways (DH, 2010b). 
Included in this programme is 
pressure ulcer prevention and the need 
to achieve an 80% reduction in hospital-
acquired pressure ulcers (grade 3–4) and 
a 30% reduction in community acquired 
pressure ulcers (grade 3–4) (DH, 2010c). 
This provides an ideal opportunity for the 
NHS and industry to work collaboratively, 
ensuring that appropriate wound care 
products are chosen that not only meet 
the needs of patients, but are also cost-
effective and evidence-based. 
Smith and Nephew are already 
committed to providing clinicians with 
education and, where possible, evidence-
based practice on all aspects of wound 
care delivery from products to business 
acumen (Glover, 2009). This will support 
the development of  new models of 
care which encompass both theoretical 
and practical approaches. 
Conclusion
Partnership working between clinicians 
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